APA (7th ed.) Citation

Stiborová, M., Černá, V., Moserová, M., Mrízová, I., Arlt, V. M., & Frei, E. (2015). The anticancer drug ellipticine activated with cytochrome P450 mediates DNA damage determining its pharmacological efficiencies: Studies with rats, hepatic cytochrome P450 reductase null (HRN™) mice and pure enzymes. International journal of molecular sciences, 16(1), . https://doi.org/10.3390/ijms16010284

Chicago Style (17th ed.) Citation

Stiborová, Marie, Věra Černá, Michaela Moserová, Iveta Mrízová, Volker M. Arlt, and Eva Frei. "The Anticancer Drug Ellipticine Activated with Cytochrome P450 Mediates DNA Damage Determining Its Pharmacological Efficiencies: Studies with Rats, Hepatic Cytochrome P450 Reductase Null (HRN™) Mice and Pure Enzymes." International Journal of Molecular Sciences 16, no. 1 (2015). https://doi.org/10.3390/ijms16010284.

MLA (9th ed.) Citation

Stiborová, Marie, et al. "The Anticancer Drug Ellipticine Activated with Cytochrome P450 Mediates DNA Damage Determining Its Pharmacological Efficiencies: Studies with Rats, Hepatic Cytochrome P450 Reductase Null (HRN™) Mice and Pure Enzymes." International Journal of Molecular Sciences, vol. 16, no. 1, 2015, https://doi.org/10.3390/ijms16010284.